Displaying drugs 7851 - 7875 of 13162 in total
GI-181771X
Gski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food Intake in Humans).
Investigational
Matched Iupac: … 3-({[(3S)-2,4-dioxo-1-phenyl-5-{[phenyl(propan-2-yl)carbamoyl]methyl}-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin …
Matched Description: … Gski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Description: … Gski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
GSK-1521498
GSK1521498 has been used in trials studying the treatment of Obesity and Alcoholism.
Investigational
Matched Iupac: … N-{[3,5-difluoro-3'-(1H-1,2,4-triazol-3-yl)-[1,1'-biphenyl]-4-yl]methyl}-2,3-dihydro-1H-inden-2-amine …
Matched Description: … GSK1521498 has been used in trials studying the treatment of Obesity and Alcoholism. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Description: … GSK1521498 has been used in trials studying the treatment of Obesity and Alcoholism. …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
DOTMP SM-153
Investigational
Matched Iupac: … ) hydrogen {[4,7-bis(hydrogen phosphonatomethyl)-10-(phosphonomethyl)-1,4,7,10-tetraazacyclododecan-1- …
SNP-ACTH (1-39)
SNP-ACTH (1-39) is a synthetic porcine Corticotropin (ACTH)
Investigational
Matched Name: … SNP-ACTH (1-39) …
Matched Description: … SNP-ACTH (1-39) is a synthetic porcine Corticotropin (ACTH) …
Matched Description: … SNP-ACTH (1-39) is a synthetic porcine Corticotropin (ACTH) …
TTX-siPDL1
TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.
Investigational
Matched Synonyms: … Magnetic nanocarrier-conjugated small interfering RNA against programmed death ligand 1 …
Matched Description: … TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1. …
Matched Description: … TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1. …
Compound 19
Experimental
Matched Iupac: … (2S,3R)-3-(4-hydroxyphenyl)-2-{4-[(2R)-2-(pyrrolidin-1-yl)propoxy]phenyl}-2,3-dihydro-1,4-benzoxathiin …
NU1025
Experimental
Matched Iupac: … 8-hydroxy-2-methyl-3,4-dihydroquinazolin-4-one …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Compound 18
Experimental
Matched Iupac: … (2S,3R)-3-(4-hydroxyphenyl)-2-{4-[(2S)-2-(pyrrolidin-1-yl)propoxy]phenyl}-2,3-dihydro-1,4-benzoxathiin …
(S)-oct-1-en-3-ol
Experimental
Matched Synonyms: … (S)-(+)-1-Octen-3-ol …
Matched Name: … (S)-oct-1-en-3-ol …
Matched Iupac: … (3S)-oct-1-en-3-ol …
Matched Name: … (S)-oct-1-en-3-ol …
Matched Iupac: … (3S)-oct-1-en-3-ol …
AT1022
AT1022 is a hydromorphone skin patch designed to provide rapid and sustained delivery of a potent opiate for the management of severe pain.
AT1022 incorporates PassPort(TM) system, developed to deliver protein and peptide drugs, small-molecule drugs, genes and vaccines across the skin for local and systemic effect.
Investigational
Matched Description: … for the management of severe pain. ... AT1022 is a hydromorphone skin patch designed to provide rapid and sustained delivery of a potent opiate …
ND1251
ND1251 is an orally active phosphodiesterase-4 (PDE4) inhibitor, a mechanism clinically proven to play a role in alleviating symptoms of depression. ND1251 is a very potent compound with a large safety margin. ND1251 may also have applications in other disorders, such as Alzheimer's disease, mild cognitive impairment, multiple sclerosis and...
Investigational
Matched Description: … phosphodiesterase-4 (PDE4) inhibitor, a mechanism clinically proven to play a role in alleviating symptoms of …
OMS-103HP
OMS103HP is the first drug being developed to improve joint function following arthroscopic surgery, one of the most common procedures performed today by orthopedic surgeons.
Investigational
Matched Description: … OMS103HP is the first drug being developed to improve joint function following arthroscopic surgery, one of …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
DOTMP HO-166
DOTMP HO-166 is used in skeletal targeted radiotherapy (STR). SRT is designed to be used in combination with high-dose chemotherapy producing a direct therapeutic effect on the tumor sites in the bone plus a general bone-marrow effect to destroy myeloma cells in the bone marrow. It is an experimental therapy...
Investigational
Matched Iupac: … lambda2-(166Ho)holmium(2+) ion {[4,7,10-tris(phosphonomethyl)-1,4,7,10-tetraazacyclododecan-1-yl]methyl …
GSK-1292263
GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
Investigational
Matched Iupac: … 2-(4-methanesulfonylphenyl)-5-({1-[3-(propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-yl}methoxy)pyridine …
Matched Description: … GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2. …
Matched Description: … GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2. …
Iodine I-125
Iodine I-125 is under investigation in clinical trial NCT00079417 (Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma).
Investigational
ISIS 104838
ISIS 104838 is under investigation in clinical trial NCT00048321 (ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis).
Investigational
Matched Description: … ISIS 104838 is under investigation in clinical trial NCT00048321 (ISIS 104838, an Inhibitor of Tumor …
GB1211
GB1211 is an orally active galectin-3 (Gal-3) inhibitor.
Investigational
Matched Iupac: … 2-[(5-bromopyridin-3-yl)sulfanyl]-6-(hydroxymethyl)-4-[4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl …
QL1706
QL1706 is an investigational bifunctional antibody that combines the activity of both PD-1 and CTLA-4 antibodies.
Investigational
Matched Description: … QL1706 is an investigational bifunctional antibody that combines the activity of both PD-1 and CTLA-4 …
SNSP113
Investigational
MT1621
Investigational
BIIB115
BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.
Investigational
MS1901
Investigational
Displaying drugs 7851 - 7875 of 13162 in total